The essence of the Duke Brain Tumor Immunotherapy Program (BTIP) is the program projects that encompass our efforts to develop safe and effective immunologic treatments for patients with invasive brain tumors.
These projects are spearheaded by an outstanding complement of graduate students, medical residents, postdoctoral fellows, and junior and senior scientists assembled under the umbrella of the Duke BTIP.
The Duke BTIP combines the necessary funding support, intellectual and physical resources, and visionary leadership to meet its devoted objective of “pioneering translational immunotherapy” for the treatment of patients with malignant brain tumors.
Our program offers the unique opportunity for junior scientists to develop an independent career while simultaneously leveraging the combined resources, intellectual input, and clinical trials infrastructure housed by the Duke BTIP, the Duke Department of Surgery, and the Preston Robert Tisch Brain Tumor Center at Duke.
Duke University Medical Center
Durham, NC 27710